Viewing StudyNCT04722978



Ignite Creation Date: 2024-05-06 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 1:54 PM
Study NCT ID: NCT04722978
Status: RECRUITING
Last Update Posted: 2022-11-08
First Post: 2021-01-21

Brief Title: Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Triple Negative Breast Cancer
Keywords: